Levothyroxine pseudomalabsorption and thyroxine absorption testing using high-dose Levothyroxine:
a case report and discussion
Running title: Pseudomalabsorption of Levothyroxine
Department of Diabetes and Endocrinology, Peterborough and Stamford NHS Trust, Edith Cavell
Hospital, Peterborough, UK
ABSTRACT
Objective:
Thyroxine replacement in patients with hypothyroidism is usually straightforward, however, a few patients continue to have elevated thyroid stimulating hormone (TSH) despite high doses of Levothyroxine.
We report a 55-year-old woman who was on 1000 mcg of Levothyroxine sodium for the treatment of hypothyroidism but still had severe biochemical hypothyroidism, and discuss the use of thyroxine absorption testing to diagnose pseudomalabsorption.
Methods:
The patient was admitted to hospital for supervised thyroxine absorption testing.
Baseline thyroid function tests were performed. An oral dose of 1000 mcg Levothyroxine was administered on an empty stomach and thyroid function tests were repeated at 2, 4 and 6 hours
post-administration.
She was also given all her prescribed antihypertensive medication and blood pressure measured every 2 hours.
Results:
Following 1000 mcg of Levothyroxine there was rapid improvement in her thyroid function results.
Similarly a rapid fall in her blood pressure was observed after taking her antihypertensive medication.
A diagnosis of non-adherence to treatment (pseudomalabsorption of Levothyroxine) was made.
Her Levothyroxine dose was reduced to 100 mcg daily and the doses of her antihypertensive medication altered accordingly
Conclusion:
We suggest that patients who are on doses of Levothyroxine more than twice their body weight, with persistently raised TSH should be investigated for malabsorption and pseudomalabsorption of Levothyroxine.
Thyroxine absorption testing using high-dose Levothyroxine is useful in diagnosing pseudomalabsorption but needs formal evaluation and validation.
Vanaf pagina 11:
Table 1 –
Patient’s thyroid function tests and Levothyroxine dose escalations over the previous years
Figure 1 –
Results of the patient’s thyroid absorption test (pre- and post-dose)
Legend for Figure 1
TSH (mU/L)
FT4 (pmol/L)
FT3 (pmol/L)
Time of dose and pretreatment values
Figure 2 –
Blood pressure response to treatment (pre- and post-dose)
Legend for Figure 2
Systolic blood pressure
Diastolic blood pressure
Time of dose and pretreatment values
Volledig artikel (15 pagina's):
http://aace.metapress.com/content/x1n04 ... lltext.pdf
